Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

Clinical trial NCT02399566 · UNKNOWN

Trial details

NCT number: NCT02399566
Sponsor: Hunan Province Tumor Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lung Adenocarcinoma

Start date: 2015-05-01
Primary completion: 2018-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.